# Assessment of the Efficacy of the Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Daily Headache in Children and Adolescents.

> **NCT05213065** · NA · UNKNOWN · sponsor: **Pablo Ingelmo** · enrollment: 120 (estimated)

## Conditions studied

- Chronic Daily Headache
- Post-Traumatic Headache

## Interventions

- **OTHER:** Sphenopalatine ganglion block with 0.5% bupivacaine
- **OTHER:** Sphenopalatine ganglion block with saline

## Key facts

- **NCT ID:** NCT05213065
- **Lead sponsor:** Pablo Ingelmo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-05
- **Primary completion:** 2024-02
- **Final completion:** 2024-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05213065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05213065, "Assessment of the Efficacy of the Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Daily Headache in Children and Adolescents.". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT05213065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*